MARYANN SMOUT: Open Payments
NPI 1780299685 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 40 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $448 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $146 |
| Otsuka America Pharmaceutical, Inc. | 9 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Calliditas Therapeutics US Inc. | 2 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Novo Nordisk Inc | 2 | $37 |
| Fresenius USA Marketing, Inc. | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
Products named: TAVNEOS, JYNARQUE, TARPEYO, PURIFIED CORTROPHIN GEL, BENLYSTA, Ozempic, Vanrafia, VELPHORO.
Industry payments across ID — which companies pay providers there.
